Edward Goldberger, MD
Rheumatology · Toledo, OHNPI 1194708131
Payments from drug & device makers
Across 449 payments — averaging $437.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$66K
- AbbVie$63K
- E.r. Squibb & Sons, L.L.C.$33K
- Amgen$21K
- Noven Pharmaceuticals, Inc.$7K
- Novartis$2K
- plus $4K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 15 | $66,293 |
| AbbVie | 139 | $63,435 |
| E.r. Squibb & Sons, L.L.C. | 23 | $33,217 |
| Amgen(2 entities) | 51 | $20,932 |
| Noven Pharmaceuticals, Inc. | 8 | $6,788 |
| Novartis | 35 | $2,026 |
| Johnson & Johnson | 22 | $634 |
| UCB, Inc. | 22 | $507 |
| AstraZeneca(2 entities) | 19 | $486 |
| Pfizer | 26 | $421 |
| GSK | 17 | $390 |
| Lilly USA, LLC | 9 | $183 |
| Mallinckrodt Hospital Products Inc. | 8 | $182 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $147 |
| Genentech USA, Inc. | 8 | $137 |
| Radius Health, Inc. | 7 | $112 |
| Organon | 4 | $98 |
| Sandoz | 3 | $88 |
| Sanofi | 4 | $79 |
| Aurinia Pharma U.S., Inc. | 4 | $78 |
| Sobi, Inc | 3 | $71 |
| Antares Pharma, Inc. | 3 | $57 |
| Boehringer Ingelheim | 2 | $45 |
| Bioventus LLC | 2 | $41 |
| Actelion Pharmaceuticals US, Inc. | 1 | $30 |
| Bristol Myers Squibb | 2 | $28 |
| Hikma Pharmaceuticals USA | 2 | $26 |
| Mallinckrodt Enterprises LLC | 1 | $23 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Sonex Health, Inc. | 1 | $17 |
| Assertio Therapeutics, Inc. | 1 | $16 |
| Abbott | 1 | $14 |
| Merck | 1 | $12 |
| Sebela Pharmaceuticals Inc. | 1 | $12 |
How this compares
$196,660 in reported general payments places this provider in the 90th percentile of 255 rheumatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Toledo
- M KahalehToledo$647K
- Nezam AltorokToledo$57K
- Aaron PumerantzToledo$11K
- Isam DiabMiddleburg Hts$15.3M
- Sanford WolfeDayton$4.7M
- Jeffrey ChaitoffSolon$3.7M
- Nora SingerCleveland$3M
- Chacko AlappattMiamisburg$2M
- Leonard CalabreseCleveland$1.9M
- Jisna PaulHilliard$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.